Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
about
Molecular cross-talk between members of distinct families of selenium containing proteinsProteomic profiling of follicular and papillary thyroid tumorsApplying of hierarchical clustering to analysis of protein patterns in the human cancer-associated liverEvidence that selenium binding protein 1 is a tumor suppressor in prostate cancerBiochemical and biophysical characterization of the selenium-binding and reducing site in Arabidopsis thaliana homologue to mammals selenium-binding protein 1Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts.Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein.Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity.Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinomaThe expression of selenium-binding protein 1 is decreased in uterine leiomyomaIdentification of phospholipid scramblase 1 as a biomarker and determination of its prognostic value for colorectal cancerIdentification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage.Proteomic analysis of differentially expressed proteins in peripheral cholangiocarcinoma.Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of seleniumRelationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular riskA combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolismIdentification and verification of heat shock protein 60 as a potential serum marker for colorectal cancer.Distribution and inhibition effect of Seleno-L-Methionine on 4T1 mouse mammary carcinoma.Altered carcinogenesis and proteome in mammary glands of rats after prepubertal exposures to the hormonally active chemicals bisphenol a and genisteinLoss of Selenium-Binding Protein 1 Decreases Sensitivity to Clastogens and Intracellular Selenium Content in HeLa Cells.A Critical Role for Cysteine 57 in the Biological Functions of Selenium Binding Protein-1.integIRTy: a method to identify genes altered in cancer by accounting for multiple mechanisms of regulation using item response theory.Downregulation of selenium-binding protein 1 is associated with poor prognosis in lung squamous cell carcinoma.Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer.Proteomic analysis of the role of S-nitrosoglutathione reductase in lipopolysaccharide-challenged mice.Toward understanding success and failures in the use of selenium for cancer prevention.Selenium-binding protein 1 as a tumor suppressor and a prognostic indicator of clinical outcome.Molecular mechanisms by which selenoproteins affect cancer risk and progression.Microarray analysis of retinal gene expression in Egr-1 knockout mice.Proteomic methodologies and their application in colorectal cancer research.Identification of biomarkers for colorectal cancer through proteomics-based approaches.Searching for consistently reported up- and down-regulated biomarkers in colorectal cancer: a systematic review of proteomic studies.Is selenium a potential treatment for cancer metastasis?Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.Proteomics for discovery of candidate colorectal cancer biomarkers.Human selenium binding protein-1 (hSP56) is a negative regulator of HIF-1α and suppresses the malignant characteristics of prostate cancer cells.Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinomaInverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue.Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma.Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases.
P2860
Q27011247-9FC5AC49-BB8B-446E-A758-3A0FA3A6A03BQ28258081-064BEE6B-8467-482C-A45C-FEAF7D6C867EQ28541543-9202942D-3EB9-4CF5-A016-7EB82CEC6B7AQ28547310-69AB4B18-F1F4-4CCC-8054-F7A803D790AEQ28652198-6B467FA0-6D2C-452C-8576-6264DC7BF3F2Q30896473-AD40529C-9409-4CE1-A5B1-808E242EAEDDQ34042351-8837F4D3-08DD-40FC-8E55-673DD8BAF32FQ34193882-954C57A0-215E-4282-890D-1FE290C7156CQ34250582-619996CE-0A33-44FF-9C6A-9781CCBC42D0Q34461489-CF74C1E6-9B1C-4CC5-A628-304FEB13EAB5Q34500667-07930345-77BC-4C11-8DEC-5212C619BA75Q34579409-328CC096-1978-4C77-9A26-46F8F2D372D4Q34618992-398C0E1F-1236-4615-B94A-FC8CBA3D244DQ34737626-FD1C517F-A978-4E88-B763-4DA78160DE38Q34893465-343DA0F9-3267-4117-B17C-35A4E18DE3FFQ35006537-1A2EA9F9-B76C-4B14-8CA9-87CC73E9B0F3Q35693568-D48A5019-2A1F-439B-A55E-A504FDEEE7DAQ35997645-8B4FC231-5875-48E5-B59F-E602FE58C5DFQ36030236-2E38A49F-BDBB-4155-98BF-55A037979A85Q36073942-DDEEF619-FA2A-45B1-BA24-A46D865819D9Q36324749-C796E1D7-D937-425B-BC69-FB286CA81972Q36393797-A7DC7F2B-3AE1-42A8-A2DE-5CCFA753A329Q36662435-EFE603CD-CD84-4631-B581-9080B4261E3DQ36663567-7E131949-6FA0-43BC-ADFB-9BAA4974A93AQ36682216-82D56DB2-F6B1-4D41-8012-03094A778CAFQ36945715-BA4DFDEC-343C-4D8D-9390-39716F453FBBQ37249829-5C550D56-4DAB-4E3A-A1E2-407654CA59C8Q37392350-7A1B7824-F39C-4E42-972D-E525ABBD21CCQ37476804-5CB7676D-5ECD-4460-BC14-1AED0252E89FQ37643738-4998A1D3-6351-494E-9AB4-83D6C1325DD9Q37818315-2DF20E3C-6D37-4F36-BD09-E23E7713AE24Q38018848-0E997081-D51C-4170-80E5-22E43C3C4D3CQ38097279-CE97DE90-38CE-4091-BAFC-945A72C36B21Q38194582-8981BF59-EF99-4CB0-A0E9-B1F1A18C648AQ38205429-041DC701-C01F-44B2-AC8D-DF0C2232FC23Q38990401-19DDE7AD-0ABE-4EE3-86A3-382050DDB8BCQ40997992-7CC869BF-AA4B-4E49-9D0D-BFF2E118BEF7Q42632704-88366A4B-81B1-4D31-8C0B-69AC2E13540DQ54434422-A7A22B36-13A4-4159-813C-31EE4442A7A1Q55315602-02CBF5DB-0F86-4CF9-9CF4-18930F4939C8
P2860
Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Suppression of human selenium- ...... associated with poor survival.
@ast
Suppression of human selenium- ...... associated with poor survival.
@en
type
label
Suppression of human selenium- ...... associated with poor survival.
@ast
Suppression of human selenium- ...... associated with poor survival.
@en
prefLabel
Suppression of human selenium- ...... associated with poor survival.
@ast
Suppression of human selenium- ...... associated with poor survival.
@en
P2093
P356
P1433
P1476
Suppression of human selenium- ...... associated with poor survival.
@en
P2093
Cheolju Lee
Hoguen Kim
Hye-Jung Kim
Hyun Ju Kang
Hyunki Kim
Kang Young Lee
Kwon Tae You
Si Young Song
Tae Il Kim
P304
P356
10.1002/PMIC.200500629
P50
P577
2006-06-01T00:00:00Z